Publications by Salaga, Maciej

Journal article

Salaga, Maciej; Binienda, Agata; Tichkule, Ritesh B.; Thakur, Ganesh A.; Makriyannis, Alexandros; Storr, Martin; Fichna, Jakub (2018): The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. In: European Journal of Pharmacology, Vol. 836: pp. 34-43

Binienda, Agata; Storr, Martin; Fichna, Jakub; Salaga, Maciej (2018): Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review. In: Current Drug Targets, Vol. 19, No. 15: pp. 1774-1781

Salaga, Maciej; Storr, Martin; Martemyanov, Kirill A.; Fichna, Jakub (2016): akademischenFestredenEmilDuBois-Reymonds(1818–1896). In: Bioessays, Vol. 38, No. 4: pp. 344-354

Zielińska, Marta; Jarmuż, Agata; Salaga, Maciej; Kordek, Radzislaw; Laudon, Moshe; Storr, Martin; Fichna, Jakub (2016): Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. In: Naunyn-Schmiedebergs Archives of Pharmacology, Vol. 389, No. 5: pp. 511-519